Verve

Gene Editing Developing therapies to safely edit the adult genome and confer lifelong protection from cardiovascular disease https://www.vervetx.com Press Releases Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A...

eGenesis

Gene Editing CRISPR-Cas 9 gene editing company focused on editing the pig genome for xenotransplantation http://www.egenesisbio.com/ Press Releases eGenesis Appoints Industry Veteran Paul Sekhri as President and Chief Executive Officer Jan 17, 2019 eGenesis Appoints...

Editas

IPO – February 2016 Gene Editing Building the leading genome editing company dedicated to treating patients with genetically defined diseases. https://editasmedicine.com Press Releases Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell...